Cidara Therapeutics Inc (CDTX)
11.21
-0.79
(-6.58%)
USD |
NASDAQ |
May 17, 16:00
11.21
0.00 (0.00%)
After-Hours: 20:00
Cidara Therapeutics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | -0.0465 |
March 31, 2022 | 0.2988 |
December 31, 2021 | 0.1201 |
Date | Value |
---|---|
September 30, 2021 | -3.195 |
June 30, 2021 | 0.3045 |
March 31, 2021 | 3.127 |
December 31, 2020 | 0.6554 |
September 30, 2020 | 0.2751 |
June 30, 2020 | 0.2233 |
March 31, 2020 | 0.1854 |
December 31, 2019 | 0.2634 |
September 30, 2019 | 0.2034 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.195
Minimum
Sep 2021
3.127
Maximum
Mar 2021
0.1271
Average
0.1201
Median
Dec 2021
Debt to Equity Ratio Benchmarks
Johnson & Johnson | 0.4803 |
NovaBay Pharmaceuticals Inc | 6.294 |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 52.72M |
Total Liabilities (Quarterly) | 70.50M |
Shareholders Equity (Quarterly) | -17.78M |
Current Ratio | 0.7158 |